Gut Bacteria Trigger ALS and Dementia Through Toxic Sugar Production
Scientists discover harmful bacterial sugars in the gut trigger immune attacks that damage the brain in ALS and dementia patients.
Alzheimer's disease research, amyloid plaques, tau tangles, and cognitive decline
368 articles
Scientists discover harmful bacterial sugars in the gut trigger immune attacks that damage the brain in ALS and dementia patients.
New research reveals how spermine promotes protein condensation and autophagy to combat neurodegeneration in lab models.
Dr. Tommy Wood discusses his new book challenging the belief that adult brains are fixed and incapable of adaptation or improvement.
Researchers captured live footage of protein clumping in Alzheimer's disease and discovered how to potentially reverse the damage.
New technique maps thousands of neural connections simultaneously, potentially revolutionizing understanding of brain aging and disease.
Comprehensive analysis of competing theories about what causes Alzheimer's and how different therapeutic approaches target each pathway.
New review examines breakthrough amyloid-targeting immunotherapies that represent the first disease-modifying treatments for Alzheimer's.
Scientists developed mitoDREADD-Gs, a novel tool that restores cognitive function by enhancing mitochondrial activity in mouse models of dementia.
New review reveals promising tau-targeting therapies showing cognitive benefits and slowed brain pathology in Alzheimer's trials.
New precision medicine approach combines genetic risk factors with environmental exposures to predict and prevent dementia.
New research identifies FTL1 protein as key driver of brain aging. Reducing it restored memory and neural connections in mice.
PEMFs repair mitochondrial damage and boost brain signaling pathways in stressed neurons, offering new therapeutic hope.